Multiple biomarkers improve diagnostic accuracy across Lewy body and Alzheimer's disease spectra.
Saved in:
| Title: | Multiple biomarkers improve diagnostic accuracy across Lewy body and Alzheimer's disease spectra. |
|---|---|
| Authors: | Plastini MJ; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.; Knight Initiative for Brain Resilience, Stanford University, Stanford, California, USA.; Wu Tsai Neurosciences Institute, Stanford University, Stanford, California, USA., Abdelnour C; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.; Knight Initiative for Brain Resilience, Stanford University, Stanford, California, USA.; Wu Tsai Neurosciences Institute, Stanford University, Stanford, California, USA., Young CB; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.; Knight Initiative for Brain Resilience, Stanford University, Stanford, California, USA.; Wu Tsai Neurosciences Institute, Stanford University, Stanford, California, USA., Wilson EN; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.; Knight Initiative for Brain Resilience, Stanford University, Stanford, California, USA.; Wu Tsai Neurosciences Institute, Stanford University, Stanford, California, USA., Shahid-Besanti M; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.; Knight Initiative for Brain Resilience, Stanford University, Stanford, California, USA.; Wu Tsai Neurosciences Institute, Stanford University, Stanford, California, USA., Lamoureux J; Amprion Clinical Laboratory, San Diego, California, USA., Andreasson KI; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.; Knight Initiative for Brain Resilience, Stanford University, Stanford, California, USA.; Wu Tsai Neurosciences Institute, Stanford University, Stanford, California, USA.; Chan Zuckerberg Biohub, San Francisco, California, 94158, USA., Kerchner GA; Pharma Research and Early Development, F. Hoffmann-La Roche, Ltd., Basel, Switzerland., Montine TJ; Knight Initiative for Brain Resilience, Stanford University, Stanford, California, USA.; Wu Tsai Neurosciences Institute, Stanford University, Stanford, California, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, California, USA., Henderson VW; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.; Wu Tsai Neurosciences Institute, Stanford University, Stanford, California, USA.; Department of Epidemiology and Population Health, Stanford University, Stanford, California, USA., Poston KL; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.; Knight Initiative for Brain Resilience, Stanford University, Stanford, California, USA.; Wu Tsai Neurosciences Institute, Stanford University, Stanford, California, USA. |
| Source: | Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2024 May; Vol. 11 (5), pp. 1197-1210. Date of Electronic Publication: 2024 Mar 04. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Wiley Periodicals, Inc on behalf of American Neurological Association Country of Publication: United States NLM ID: 101623278 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2328-9503 (Electronic) Linking ISSN: 23289503 NLM ISO Abbreviation: Ann Clin Transl Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2328-9503 |
|---|---|
| DOI: | 10.1002/acn3.52034 |
